GO
Loading...

Teva Pharmaceutical Industries Ltd

More

  • Cramer makes the call on viewers' favorite stocks.

  • Market Insider: Thursday Look Ahead Wednesday, 5 Nov 2008 | 9:26 PM ET

    Thursday's chain store sales numbers could set the tone for a market obsessed with the weakening economy.

  • Stock Picks: Energy, Healthcare & Financials Wednesday, 1 Oct 2008 | 12:41 PM ET

    Dan Genter, of RNC Genter Capital Mangement, believes Congress will pass a bailout package by the end of the week, but he expects the next day or two to be wildly volatile and painful. Despite this, he sees opportunities in stocks that have been unjustly beat up.

  • What the Pros Say: Diversity & Dividends Wednesday, 1 Oct 2008 | 8:38 AM ET
    WALL STREET IN CRISIS - A CNBC SPECIAL REPORT

    With Congress rejecting a Wall Street bailout, markets are turning towards central banks hoping they will stop the decline.

  • S&P Slammed Monday, 22 Sep 2008 | 5:56 PM ET

    The Dow tumbled on Monday as investors worried a $700 billion bailout for the financial sector may not resuscitate a slumping economy...

  • Lightning Round OT: Teva Pharma, Gushan and More Wednesday, 17 Sep 2008 | 6:36 PM ET

    The Lightning Round is extended in this CNBC.com exclusive feature.

  • Options Flag Watson As Takeover Target Thursday, 14 Aug 2008 | 8:54 AM ET

    Options action on Watson Phamaceuticals indicates that traders think it might be a takeover target, according to one options experts

  • Buy Biotech Monday, 11 Aug 2008 | 11:38 PM ET

    Cramer offers up five reasons why this sector is the best one to own through the fall. Plus, the top stocks in the group.

  • As we enter day two of the qualifying rounds, all major indices were down but Australia's ASX has taken the lead, followed by India's Bombay Sensex.  In our poll's early voting, many of you suggested that Israel's T25 might be in contention for a medal despite a rough couple of days.  Here are some stats and stocks from Israel.

  • Week Ahead: Volatile Stocks, Oil Watch, Fed on Hold Monday, 4 Aug 2008 | 11:12 AM ET

    Oil prices will be the trigger for stocks in the week ahead. The Fed meets Tuesday and as usual, traders will watch for nuances in the Fed's post-meeting statement.

  • Quick Market Stats: July 2008 Wrap Thursday, 31 Jul 2008 | 5:11 PM ET

    On a down day for the markets and with the exception of the S&P 500, the month of July finished with the major US indices showing modest gains.

  • Bank Rally Helps Stocks Snap Losing Streak Friday, 18 Jul 2008 | 6:11 PM ET

    Stocks finished the day mixed, as disappointing earnings from Microsoft and Google dragged down techs, but gained 3.6 percent for the week, helped by a rally in bank stocks and a sharp drop in oil prices.  Oil ended the week down 11 percent at $128.88 a barrel.

  • For the week ending Friday, July 18, 2008, the U.S. markets saw extreme volatility yet settled higher on better-than-expected earnings results, a pullback in crude oil, and an indication that the Fed will hold interest rates steady.  Nonetheless, the Dow had its best week since April 18 and its best 3-day percent gain since March 2003 even after closing below 11,000 for the first time since July 2006. 

  • Stocks Wobble as Rally Can't Find Legs Friday, 18 Jul 2008 | 3:18 PM ET

    Stocks turned mixed Friday as banks rebounded and Google and Microsoft slammed techs.

  • Stocks Mixed as Banks Bounce, Oil Recedes Friday, 18 Jul 2008 | 1:24 PM ET

    Stocks turned mixed Friday as banks rebounded and Google and Microsoft slammed techs.

  • Teva to Buy Barr for $7.5 Billion, Boosts Generic Lead Friday, 18 Jul 2008 | 10:41 AM ET
    The Horsham, Pa., offices of Teva Pharmaceuticals North America are shown Monday, July 25, 2005.   In a deal that will create the world's largest generic drug company, Teva Pharmaceutical Industries Ltd. said Monday it is acquiring rival Ivax Corp. for about $7.4 billion (6.13 billion euros) in cash and stock. Ivax shares climbed 10 percent in morning trading.  (AP Photo/George Widman)

    Teva Pharmaceutical Industries said on Friday it would buy rival generic drugmaker Barr Pharmaceuticals for $7.46  billion to expand its leadership in the U.S. market and fortify its presence in Europe.

  • Options Play on Teva-Barr, AutoNation, and Carnival Thursday, 17 Jul 2008 | 7:57 AM ET

    Options move on pharmaceutical speculation and oil price drops.

  • The Fast Money Misfires – Friday July 11th Friday, 11 Jul 2008 | 6:49 PM ET

    Sometimes a stock is hot and other time it just burns. Following are the Fast Money misfires.

  • Oil Drops, Stocks Pop Tuesday, 8 Jul 2008 | 5:51 PM ET

    The Dow rose Tuesday in another turbulent session after a pullback in oil prices eased worries about consumer and business spending. What's the "Word on the Street?"

  • Pops & Drops: General Motors, Teva... Monday, 7 Jul 2008 | 6:20 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of General Motors and Dryships popped while Teva and RBS dropped.